Rubicon Research Limited (BOM:544578)
India · Delayed Price · Currency is INR 1,431.35
+25.15 (1.79%)
At close: Jul 10, 2026
Rubicon Research Market Cap
Rubicon Research has a market cap or net worth of 236.94 billion as of July 13, 2026.
Market Cap
236.94B
Enterprise Value
236.59B
Revenue
17.54B
Ranking
n/a
PE Ratio
96.03
Stock Price
1,431.35
Market Cap Chart
Since October 16, 2025, Rubicon Research's market cap has increased from 103.50B to 236.94B, an increase of 128.94%. That is a compound annual growth rate of 206.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 13, 2026 | 236.94B | 111.27% |
| Dec 31, 2025 | 112.15B | 8.37% |
| Oct 16, 2025 | 103.50B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Abbott India | 576.39B |
| GlaxoSmithKline Pharmaceuticals | 412.59B |
| J. B. Chemicals & Pharmaceuticals | 391.39B |
| Rubicon Research | 235.82B |
| Granules India | 220.43B |
| AstraZeneca Pharma India | 203.10B |
| Caplin Point Laboratories | 196.52B |
| Jubilant Pharmova | 152.20B |